Skip to main content
. 2018 Feb 23;18:59. doi: 10.1186/s12877-018-0750-2

Table 3.

Factors influencing rate of polypharmacy in older patients with multilevel adjusted final models

Variables Overall,
OR (95% CI)
Public sector,
OR (95% CI)
Private sector,
OR (95% CI)
Patient level
 Age, median (IQR) 0.99 (0.96–1.02) 1.00 (0.96–1.04) 0.99 (0.94–1.04)
 Gender Reference: Male
 Female 1.49 (1.11–1.99)* 1.76 (1.17–2.65)* 1.08 (0.53–2.19)
 Ethnicity Reference: Malay
 Chinese 0.94 (0.58–1.53) 0.93 (0.50–1.74) 1.65 (0.23–1.63)
 Indian 1.11 (0.56–2.18) 1.21 (0.53–2.77) 0.45 (0.06–3.29)
 Other 2.16 (0.49–9.52) 1.02 (0.35–3.02) 4.20 (0.62–28.24)
 Education level Reference: No formal education
 Primary 1.61 (1.12–2.32)* 1.68 (1.00–2.83) 1.69 (0.61–4.67)
 Secondary 1.44 (0.93–2.23) 1.85 (0.99–3.46) 1.73 (0.59–5.05)
 Tertiary 1.08 (0.47–2.5) 1.62 (0.51–5.17) 0.60 (0.07–5.34)
 Multimorbidity Reference: No
 Yes 14.21 (8.46–23.88)* 36.37 (17.39–76.09)* 5.54 (2.03–15.13)*
Prescriber level
 Experience 1.01 (0.97–1.05) 1.02 (0.96–1.09) 1.00 (0.96–1.06)
 Working hours 1.00 (0.97–1.03) 0.97 (0.92–1.02) 1.01 (0.97–1.04)
 Gender Reference: Male
 Female 1.14 (0.63–2.04) 0.64 (0.32–1.29) 0.83 (0.27–2.55)
 FMS Reference: No
 Yes 2.81 (0.79–9.91) 4.66 (1.11–19.5)*
 Place of graduation Reference: Foreign
 Local 1.16 (0.76–1.78) 0.96 (0.52–1.80) 0.78 (0.31–1.97)
Practice level
 Workload 0.99 (0.97–1.00) 0.98 (0.97–1.00) 0.98 (0.96–1.01)
 Sector Reference: Private
 Public 6.37 (1.17–34.71)*
Operation day per week Reference: Five
 Six 1.35 (0.50–3.62) 1.31 (0.76–2.24) 2.22 (0.17–29.28)
 Seven 2.73 (0.88–8.45) 1.80 (0.20–16.27) 4.44 (0.29–67.57)
 Practice with FMS Reference: No
 Yes 1.56 (0.63–3.84) 0.93 (0.41–2.09) 7.68 (0.72–82.32)
 Practice type Reference: Group
 Solo 3.09 (0.94–10.11) 2.91 (0.16–53.1) 4.36 (0.98–19.31)
 Urban location Reference: No
 Yes 0.74 (0.33–1.64) 0.78 (0.44–1.41) 0.82 (0.19–3.50)

OR, odds ratio; CI, confidence interval; IQR, interquartile range; FMS, family medicine specialist; Multimorbidity refers to having 2 or more chronic conditions; * p-value < .05